| Ezetimibe (n  = 17) | p − value | Atorvastatin (n  = 16) | p − value | ||||
---|---|---|---|---|---|---|---|---|
 | Baseline |  | 6 months |  | Baseline |  | 6 months |  |
Hemoglobin A1c (%) | 7.3 ± 1.1 |  | 7.5 ± 0.8 | 0.307 | 6.9 ± 0.6 |  | 6.7 ± 0.7 | 0.062 |
% change (%) |  | 3.9 ± 13.3 |  |  |  | −0.3 ± 2.1 |  |  |
Fasting plasma glucose (mg/dL) | 135.8 ± 21.5 |  | 135.8 ± 27.9 | 0.581 | 131.4 ± 21.4 |  | 133.9 ± 25.5 | 0.651 |
% change (%) |  | 2.6 ± 15.3 |  |  |  | 2.8 ± 7.8 |  |  |
Total cholesterol (mg/dL) | 237.5 ± 25.8 |  | 195.7 ± 21.6 | <0.001 | 226.6 ± 29.5 |  | 174.4 ± 22.2 | <0.001 |
% change (%) |  | −17.1 ± 9.3‡ |  |  |  | −22.8 ± 6.1‡ |  |  |
LDL cholesterol (mg/dL) | 148.8 ± 22.1 |  | 115.5 ± 17.9 | <0.001 | 135.6 ± 19.7 |  | 88.9 ± 17.5 | <0.001 |
% change (%) |  | −21.9 ± 9.6* |  |  |  | −34.5 ± 7.8* |  |  |
HDL cholesterol (mg/dL) | 57.0 ± 11.3 |  | 54.9 ± 12.6 | 0.31 | 54.9 ± 19.0 |  | 58.0 ± 18.5 | 0.035 |
% change (%) |  | −3.4 ± 12.1‡ |  |  |  | 6.5 ± 10.5‡ |  |  |
Triglyceride (mg/dL) | 112.0 (100.0–192.5) |  | 94.0 (80.0–171.0) | 0.18 | 134.5 (76.3–229.3) |  | 105 (67.0–188.3) | 0.12 |
% change (%) |  | −8.9 ± 28.1 |  |  |  | −7.0 ± 45.0 |  |  |
NEFA (mg/dL) | 561.1 ± 236.8 |  | 429.7 ± 195.9 | 0.009 | 538.8 ± 319.5 |  | 520.2 ± 227.3 | 0.746 |
% change (%) |  | −19.9 ± 27.4‡ |  |  |  | 11.3 ± 44.1‡ |  |  |
Lathosterol (μg/mL) | 3.30 ± 1.45 |  | 4.60 ± 1.96 | 0.004 | 3.44 ± 1.52 |  | 1.57 ± 0.61 | <0.001 |
% change (%) |  | 51.2 ± 52.2* |  |  |  | −42.0 ± 49.7* |  |  |
Campesterol (μg/mL) | 6.14 ± 2.74 |  | 2.69 ± 0.72 | <0.001 | 6.56 ± 1.53 |  | 6.21 ± 1.86 | 0.217 |
% change (%) |  | −51.0 ± 17.7* |  |  |  | −6.5 ± 23.3* |  |  |
Lathosterol/campesterol | 0.457 (0.337–1.006) |  | 1.428 (1.189–2.303) | <0.001 | 0.593 (0.282–0.678) |  | 0.276 (0.205–0.311) | 0.002 |
% change (%) |  | 239.3 ± 38.5* |  |  |  | −39.2 ± 38.5* |  |  |
LnRHI | 0.471 ± 0.157 |  | 0.678 ± 0.187 | 0.007 | 0.552 ± 0.084 |  | 0.558 ± 0.202 | 0.645 |
% change (%) |  | 63.3 ± 89.2‡ |  |  |  | 7.4 ± 41.2‡ |  |  |